Company: PTHS
Filing Date: 2025-12-23
Form Type: 8-K
Source: 0001753926-25-001964
Chunk: 0

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-12-23
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item
8.01 Other Events.

On December 23, 2025, the Company issued a press release
announcing the appointment of Mr. Einhorn to the Board. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated
herein by reference.

Cautionary Statement Regarding Forward-Looking
Statements

This Current Report on Form 8-K and Exhibit 99.1
contain forward-looking statements. Forward-looking statements include, but are not limited to, statements that express the Company's
intentions, beliefs, expectations, strategies, predictions or any other statements related to the Company's future activities, or future
events or conditions. These statements are based on current expectations, estimates and projections about the Company's business based,
in part, on assumptions made by its management. These statements are not guarantees of future performance and involve risks, uncertainties
and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or
forecasted in the forward-looking statements due to numerous factors, including those risks that may be included in documents that the
Company files from time to time with the SEC. Any forward-looking statements speak only as of the date on which they are made, and the
Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this Current
Report on Form 8-K, except as required by law.

Item
9.01 Financial Statements and Exhibits